Literature DB >> 2115893

Treatment of depersonalization with serotonin reuptake blockers.

E Hollander1, M R Liebowitz, C DeCaria, J Fairbanks, B Fallon, D F Klein.   

Abstract

Eight patients with depersonalization disorder or with depersonalization symptoms in association with obsessive-compulsive and panic disorders were treated with serotonin reuptake blockers. There was clinical overlap of depersonalization disorder with obsessive-compulsive disorder, and the co-occurrence of obsessive-compulsive and panic features with depersonalization in these patients was associated with a favorable treatment outcome. The chronicity of illness and lack of prior response to a variety of treatments in these patients highlights the positive outcome with this treatment. In addition, issues are raised regarding the current hierarchical exclusion of depersonalization disorder in the presence of obsessive-compulsive and panic disorders.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2115893

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


  3 in total

Review 1.  Depersonalisation disorder: a contemporary overview.

Authors:  Daphne Simeon
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

2.  Evidence-based treatment for Depersonalisation-derealisation Disorder (DPRD).

Authors:  Eli Somer; Taryn Amos-Williams; Dan J Stein
Journal:  BMC Psychol       Date:  2013-10-28

3.  The Potential Role of Naltrexone in Borderline Personality Disorder.

Authors:  Azadeh Moghaddas; Mehrnoush Dianatkhah; Saba Ghaffari; Padideh Ghaeli
Journal:  Iran J Psychiatry       Date:  2017-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.